高级检索
当前位置: 首页 > 详情页

DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Hepat Surg Ctr,Wuhan,Peoples R China [2]ChinaClin Med Res Ctr Hepat Surg Hubei Prov, Wuhan, Peoples R China [3]Minist Educ, Key Lab Organ Transplantat, Wuhan, Peoples R China [4]Natl Hlth Commiss, Key Lab Organ Transplantat, Wuhan, Peoples R China [5]Chinese Acad Med Sci, Key Lab Organ Transplantat, Wuhan, Peoples R China [6]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dermatol,Wuhan,Peoples R China [7]Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Biochem & Mol Biol, Wuhan, Hubei, Peoples R China [8]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Canc Res Inst,Wuhan 430030,Hubei,Peoples R China
出处:
ISSN:

摘要:
Discoidin domain receptor 1 (DDR1) is a member of the receptor tyrosine kinase family, and its ligand is collagen. Previous studies demonstrated that DDR1 is highly expressed in many tumors. However, its role in hepatocellular carcinoma (HCC) remains obscure. In this study, we found that DDR1 was upregulated in HCC tissues, and the expression of DDR1 in TNM stage II-IV was higher than that in TNM stage I in HCC tissues, and high DDR1 expression was associated with poor prognosis. Gene expression analysis showed that DDR1 target genes were functionally involved in HCC metastasis. DDR1 positively regulated the migration and invasion of HCC cells and promoted lung metastasis. Human Phospho-Kinase Array showed that DDR1 activated ERK/MAPK signaling pathway. Mechanically, DDR1 interacted with ARF6 and activated ARF6 through recruiting PSD4. The kinase activity of DDR1 was required for ARF6 activation and its role in metastasis. High expression of PSD4 was associated with poor prognosis in HCC. In summary, our findings indicate that DDR1 promotes HCC metastasis through collagen induced DDR1 signaling mediated PSD4/ARF6 signaling, suggesting that DDR1 and ARF6 may serve as novel prognostic biomarkers and therapeutic targets for metastatic HCC.

基金:

基金编号: 81372327 81874149 81874189 81572855 81572427 81874065 2018ZX10723204-003 2018YFA0208904 CXPJJH11800001-2018356 5001540059 5001540006 2018ACA137

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 1 区 医学
小类 | 1 区 生化与分子生物学 1 区 肿瘤学 1 区 遗传学 2 区 细胞生物学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 生化与分子生物学 1 区 遗传学 2 区 细胞生物学 2 区 肿瘤学
JCR分区:
出版当年[2020]版:
Q1 GENETICS & HEREDITY Q1 CELL BIOLOGY Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 ONCOLOGY
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 CELL BIOLOGY Q1 GENETICS & HEREDITY Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Hepat Surg Ctr,Wuhan,Peoples R China [2]ChinaClin Med Res Ctr Hepat Surg Hubei Prov, Wuhan, Peoples R China [3]Minist Educ, Key Lab Organ Transplantat, Wuhan, Peoples R China [4]Natl Hlth Commiss, Key Lab Organ Transplantat, Wuhan, Peoples R China [5]Chinese Acad Med Sci, Key Lab Organ Transplantat, Wuhan, Peoples R China [6]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dermatol,Wuhan,Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Hepat Surg Ctr,Wuhan,Peoples R China [2]ChinaClin Med Res Ctr Hepat Surg Hubei Prov, Wuhan, Peoples R China [3]Minist Educ, Key Lab Organ Transplantat, Wuhan, Peoples R China [4]Natl Hlth Commiss, Key Lab Organ Transplantat, Wuhan, Peoples R China [5]Chinese Acad Med Sci, Key Lab Organ Transplantat, Wuhan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:589 今日访问量:0 总访问量:441 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)